U
HTG Molecular Diagnostics, Inc. HTGMQ
$0.0001 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

03/31/2023 12/31/2022 09/30/2022 06/30/2022 03/31/2022
Net Income -7.72% -3.91% 23.30% 9.38% -25.16%
Total Depreciation and Amortization -13.90% -25.26% -20.26% -9.54% 21.32%
Total Amortization of Deferred Charges -14.52% -17.24% -7.39% -6.88% -1.26%
Total Other Non-Cash Items -45.06% 599.84% -56.85% 2.34% -24.81%
Change in Net Operating Assets -115.03% 337.91% 25.15% -305.77% -116.94%
Cash from Operations -115.68% 55.97% 21.44% 1.52% -75.21%
Capital Expenditure -- 100.00% -344.44% 67.86% 84.33%
Sale of Property, Plant, and Equipment -- -100.00% -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -207.22% -34.65% 457.98% -126.12% 89.42%
Cash from Investing -207.41% -35.82% 463.80% -126.21% 92.75%
Total Debt Issued -- -100.00% -- -- --
Total Debt Repaid 36.12% 66.04% -178.60% 5.44% -459.92%
Issuance of Common Stock -- -- -- -- 1,942.83%
Repurchase of Common Stock 50.00% 99.02% 92.01% -6,192.59% -1,057.14%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -395.22% 10.99% -141.67% 144.30% -304.17%
Cash from Financing -117.01% 350.21% -94.30% -128.46% 16,714.93%
Foreign Exchange rate Adjustments -81.78% 263.36% -19.09% -205.56% -9.09%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -202.40% 453.70% 71.28% -276.64% 896.33%
Weiss Ratings